TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Pensa Pharma AB
Closing information (x1000 DKK)
| Closing information | 2024/03 | 2023/03 | 2021/12 |
| Turnover |
9,813
|
21,128
|
28,535 |
| Financial expenses |
12
|
67
|
1 |
| Earnings before taxes |
-1,094
|
-2,447
|
782 |
| EBITDA |
898
|
-2,200
|
732 |
| Total assets |
10,987
|
18,895
|
21,173 |
| Current assets |
10,971
|
14,869
|
12,888 |
| Current liabilities |
2,115
|
6,785
|
5,083 |
| Equity capital |
8,873
|
12,111
|
16,089 |
| - share capital |
647
|
661
|
727 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/03 | 2023/03 | 2021/12 |
| Solvency |
80.8%
|
64.1%
|
76.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-11.1%
|
-11.6%
|
2.7% |
| Return on assets (ROA) |
-9.8%
|
-12.6%
|
3.7% |
| Current ratio |
518.7%
|
219.1%
|
253.6% |
| Return on equity (ROE) |
-12.3%
|
-20.2%
|
4.9% |
| Change turnover |
-10,884
|
-4,796
|
12,219 |
| Change turnover % |
-53%
|
-19%
|
75% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/03 | 2023/03 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.